OpenBilldrug price receipt

NADAC week of 2026-10-14

EPANED 1 MG/ML ORAL SOLUTION

FDA nonproprietary name: enalapril maleate

For 150 mL

Pharmacies pay

$671.77 filed

150 × $4.47849 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$595.86 filed

150 × $3.97238 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.89× estimated

Medicare paid 11% less than pharmacies pay.

Part D averages every strength and form sold under “Epaned” / “Enalapril Maleate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$777.54 estimated

$671.77 + $100.77 (15%) + $5.00 fee per fill = $777.54

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

EPANED 1 MG/ML ORAL SOLUTION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as enalapril maleate, under the trade name “Epaned”.

FDA gives its dosage form as solution and its route as oral.

The labeler, the company named on the label, is Azurity Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Angiotensin Converting Enzyme Inhibitor.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 52652-4001-01.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $671.77 for 150 mL (150 × $4.47849 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.7946 per ML filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

The NDC

Other strengths, forms and brands

5 other products in the NADAC file share the FDA nonproprietary name enalapril maleate with EPANED 1 MG/ML ORAL SOLUTION.

ProductPharmacies pay per unitMedicare per unit
ENALAPRIL 1 MG/ML ORAL SOLN
generic · solution
$0.7946 per ML filed
eff. 2026-09-23
We don’t know yet
ENALAPRIL MALEATE 2.5 MG TAB
generic · tablet
$0.06251 per EA filed
eff. 2026-09-23
$0.18113 per EA filed
Part D 2024 average
ENALAPRIL MALEATE 5 MG TABLET
generic · tablet
$0.0724 per EA filed
eff. 2026-09-23
$0.18113 per EA filed
Part D 2024 average
ENALAPRIL MALEATE 10 MG TAB
generic · tablet
$0.06635 per EA filed
eff. 2026-09-23
$0.18113 per EA filed
Part D 2024 average
ENALAPRIL MALEATE 20 MG TAB
generic · tablet
$0.09526 per EA filed
eff. 2026-09-23
$0.18113 per EA filed
Part D 2024 average
EPANED 1 MG/ML ORAL SOLUTION this page
brand · solution
$4.47849 per ML filed
eff. 2026-09-23
$3.97238 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $595.86 for 150 mL, at an average of $3.97238 per ML in 2024 (2024-01-01 to 2024-12-31) for “Epaned” and “Enalapril Maleate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 63 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for EPANED 1 MG/ML ORAL SOLUTION labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Epaned / Enalapril Maleate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
Why does this page start at 150 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 150 mL in one package for this product’s NDC (“150 mL in 1 BOTTLE (52652-4001-1)”), so the card starts at one package: 150 ML. Change it to match your prescription.